logo
Sign In
  1. Home
  2. Search
FiltersReset Filters
10 results
  • amlodipine and olmesartan medoxomil - amlodipine and olmesartan medoxomil tablet, film coated

    (Amlodipine And Olmesartan Medoxomil)
    Medication Details
    Sciegen Pharmaceuticals, Inc
    Medication Details
  • clotrimazole topical solution usp, 1%- clotrimazole topical solution usp, 1% solution

    (Clotrimazole Topical Solution Usp, 1%)
    Medication Details
    Sciegen Pharmaceuticals, Inc
    Medication Details
  • diltiazem hydrochloride - diltiazem hydrochloride tablet

    (Diltiazem Hydrochloride)
    Medication Details
    Sciegen Pharmaceuticals, Inc
    Medication Details
  • fluoxetine - fluoxetine tablet, film coated

    (Fluoxetine)
    Medication Details
    Sciegen Pharmaceuticals, Inc
    Medication Details
  • levetiracetam  extended - release - levetiracetam tablet, film coated, extended release

    (Levetiracetam)
    Medication Details
    Sciegen Pharmaceuticals, Inc
    Medication Details
  • naproxen and esomeprazole magnesium - naproxen and esomeprazole magnesium tablet, delayed release

    (Naproxen And Esomeprazole Magnesium)
    Medication Details
    Sciegen Pharmaceuticals, Inc
    Medication Details
  • pregabalin

    (Pregabalin)
    Medication Details
    Sciegen Pharmaceuticals, Inc
    Medication Details
    Drug Interactions
  • pregabalin - pregabalin capsule

    (Pregabalin)
    Medication Details
    Sciegen Pharmaceuticals, Inc
    Medication Details
  • quetiapine

    (Quetiapine)
    Medication Details
    ScieGen Pharmaceuticals, Inc
    Usage: Quetiapine extended-release tablets are indicated for treating schizophrenia, acute episodes of bipolar I disorder (manic, mixed, depressive), and as adjunctive therapy for major depressive disorder. Pediatric indications require careful diagnostic evaluation and consideration of risks. Treatment should be integrated with psychological and social interventions.
    Medication Details
    Drug Interactions
  • ranolazine

    (RANOLAZINE)
    Medication Details
    ScieGen Pharmaceuticals, Inc
    Usage: Ranolazine extended-release tablets are indicated for treating chronic angina, and can be used alongside various medications, including beta-blockers, nitrates, and ACE inhibitors.
    Medication Details
    Drug Interactions
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutCareersContact UsSecurity
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.